Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours-Authors' reply.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
    • Publication Information:
      Publication: Oxford : Wiley-Blackwell
      Original Publication: [Oxford, OX] : Blackwell Scientific Publications, [c1987-
    • Subject Terms:
      Gastrointestinal Diseases* ; Neoplasms*/drug therapy ; Communicable Diseases* ; Cytomegalovirus Infections*/diagnosis ; Cytomegalovirus Infections*/drug therapy; Humans
    • Comments:
      Comment on: Aliment Pharmacol Ther. 2022 Nov;56(9):1370-1382. (PMID: 36123319)
    • References:
      Parente P, Ascani S, Maiorano BA, Zanelli M, Ciardiello D. Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in Tumours. Aliment Pharmacol Ther. 2023;57:916-17.
      Roblin X, Pillet S, Oussalah A, Berthelot P, Del Tedesco E, Phelip JM, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol. 2011;106(11):2001-8. https://doi.org/10.1038/AJG.2011.202.
      Franklin C, Rooms I, Fiedler M, Reis H, Milsch L, Herz S, et al. Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis. Ann Oncol. 2017;28:v421-2. https://doi.org/10.1093/annonc/mdx376.055.
      van Turenhout ST, Berghuis M, Snaebjornsson P, Wilgenhof S, Burgers JA, Haanen JBAG, et al. Cytomegalovirus in steroid-refractory immune checkpoint inhibition-related colitis. J Thorac Oncol. 2020;15(1):e15-20. https://doi.org/10.1016/j.jtho.2019.07.026.
      Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, et al. ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis. 2021;15:879-913. https://doi.org/10.1093/ecco-jcc/jjab052.
      Dahl EK, Abed OK, Kjeldsen J, Donia M, Svane IM, Dige A, et al. Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis. Aliment Pharmacol Ther. 2022;56(9):1370-82. https://doi.org/10.1111/APT.17201.
    • Publication Date:
      Date Created: 20230323 Date Completed: 20230327 Latest Revision: 20230509
    • Publication Date:
      20230512
    • Accession Number:
      10.1111/apt.17431
    • Accession Number:
      36952273